The global Microbiome Therapeutics Market is on the verge of a transformative decade. Valued at USD 0.3 billion in 2025, the ...

Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in ...

DelveInsight’s “Crohn's Disease Market Insights, Epidemiology, and Market Forecast–2034” provides a comprehensive analysis of ...

Objective Certain leading medical organisations are considering alternatives to the Body Mass Index (BMI) as a predictor of the risk for non-communicable chronic disease (NCD) or death. Our objective ...

The NHS is offering three Covid treatments as the "more infectious" Nimbus variant continues to spread across the UK. The ...

The presence of IBD among patients with axSpA was not linked to an increased risk for active axSpA or radiographic progression.

Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In an effort to develop targeted treatments for gut pain, scientists have ...

Eli Lilly’s Omvoh (mirikizumab-mrkz) has shown continued benefit after four years in a Phase III open-label extension trial ...

The former England captain, nicknamed ‘Mad Dog’ for his fearless and relentless playing style, is already impressively ...

The clinical and molecular heterogeneity of IBD—both between patients and within the same individual over time—continues to ...

Patients with IBD and confirmed sarcopenia had a 140% increased mortality risk compared with the normal group (HR, 2.40; 95% CI, 1.27-4.52; P =.007). Individuals without IBD and with confirmed ...

Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...